Leerink Partnrs Has Positive Outlook for EHC Q1 Earnings

Encompass Health Co. (NYSE:EHC) – Leerink Partnrs upped their Q1 2025 earnings per share estimates for shares of Encompass Health in a report issued on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $1.26 per share for the quarter, up from their prior forecast of $1.21. The consensus estimate for Encompass Health’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Encompass Health’s Q3 2025 earnings at $1.15 EPS, Q4 2025 earnings at $1.30 EPS, FY2025 earnings at $4.90 EPS, Q1 2026 earnings at $1.29 EPS, Q3 2026 earnings at $1.17 EPS, Q4 2026 earnings at $1.34 EPS and FY2026 earnings at $5.01 EPS.

Several other equities analysts have also commented on the company. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday. Truist Financial reissued a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a report on Friday, February 7th. Finally, Barclays lifted their price target on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Down 1.4 %

Shares of NYSE:EHC opened at $98.04 on Wednesday. The firm has a fifty day moving average of $96.06 and a 200 day moving average of $95.43. Encompass Health has a 52-week low of $72.53 and a 52-week high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market capitalization of $9.88 billion, a PE ratio of 21.98, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%.

Institutional Trading of Encompass Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB raised its holdings in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares in the last quarter. UMB Bank n.a. lifted its stake in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC boosted its position in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC purchased a new stake in Encompass Health in the third quarter worth $40,000. Finally, CBIZ Investment Advisory Services LLC raised its holdings in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after purchasing an additional 127 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.